Authors |
Burballa, Carla ; Cantero-Recasens, Gerard ; Prikhodina, Larisa ; Lugani, Francesca ; Schlingmann, Karlpeter ; Ananin, Petr V ; Besouw, Martine ; Bockenhauer, Detlef ; Madariaga, Leire ; Bertholet-Thomas, Aurelia ; Taroni, Francesca ; Parolin, Mattia ; Conlon, Peter ; Delprete, Dorella ; Chauveau, Dominique ; Koster-Kamphuis, Linda ; Fila, Marc ; Pasini, Andrea ; Castro, Isabel ; Colussi, Giacomo ; Gil, Marta ; Mohidin, Barian ; Wlodkowski, Tanja ; Schaefer, Franz ; Ariceta, Gema |
Abstract [eng] |
Dent's disease type 1 (DD1) is a rare X-linked nephropathy caused by CLCN5 mutations, characterized by proximal tubule dysfunction, including low-molecular-weight proteinuria (LMWP), hypercalciuria, nephrolithiasis-nephrocalcinosis, progressive chronic kidney disease (CKD) and kidney failure (KF). Current management is symptomatic and does not prevent disease progression. Here we describe the contemporary DD1 picture across Europe to highlight its unmet needs. |